Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery

Bone Marrow Transplantation volume 36, pages 39–50 (2005)Cite this article

Summary:

Adenovirus (HAdV) infections are a frequent cause of morbidity and mortality after allogeneic human stem cell transplantation (HSCT). We report a retrospective single-centre study on 328 consecutive paediatric recipients of an allogeneic HSCT. During the first 6 months after HSCT, HAdV infection occurred in 37 children (cumulative incidence 12%). The highest incidence was found in young children up to 5 years of age, transplanted after 1994, with >2 log T-cell depletion of a graft of another than an HLA-genotypically identical related donor (actuarial frequency at 6 months 84%). Persistence of HAdV and spreading of the virus over multiple sites showed a trend towards the development of HAdV disease or death, but did not reach significance. Recovery of immunity after HSCT, that is, serum concentrations of IgM and peripheral blood counts of T cells and subsets, was delayed in children with an HAdV infection compared with noninfected children. In seven out of seven patients with HAdV DNA in serum and decreasing lymphocyte counts, the infection had a fatal course. Manipulation of cellular immunity either by tapering of immunosuppression, infusion of donor lymphocytes or immunotherapy using HAdV-specific T cells should be considered in graft recipients at risk for a severe HAdV infection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Meyers JD, Flournoy N, Thomas ED . Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478–488.

    Article  CAS  PubMed  Google Scholar 

  2. Hebart H, Brugger W, Grigoleit U et al. Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality. Blood 2001; 97: 2183–2185.

    Article  CAS  PubMed  Google Scholar 

  3. Gross TG, Steinbuch M, DeFor T et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant 1999; 23: 251–258.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hale G, Waldmann H . Risks of developing Epstein–Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users. Blood 1998; 91: 3079–3083.

    CAS  PubMed  Google Scholar 

  5. Hale GA, Heslop HE, Krance RA et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999; 23: 277–282.

    Article  CAS  PubMed  Google Scholar 

  6. Runde V, Ross S, Trenschel R et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001; 28: 51–57.

    Article  CAS  PubMed  Google Scholar 

  7. Bordigoni P, Carret AS, Venard V et al. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2001; 32: 1290–1297.

    Article  CAS  PubMed  Google Scholar 

  8. Hoffman JA, Shah AJ, Ross LA, Kapoor N . Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 388–394.

    Article  CAS  PubMed  Google Scholar 

  9. Flomenberg P, Babbitt J, Drobyski WR et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994; 169: 775–781.

    Article  CAS  PubMed  Google Scholar 

  10. Howard DS, Phillips II GL, Reece DE et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 1999; 29: 1494–1501.

    Article  CAS  PubMed  Google Scholar 

  11. Baldwin A, Kingman H, Darville M et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000; 26: 1333–1338.

    Article  CAS  PubMed  Google Scholar 

  12. Morfin F, Boucher A, Najioullah F et al. Cytomegalovirus and adenovirus infections and diseases among 75 paediatric unrelated allogeneic bone marrow transplant recipients. J Med Virol 2004; 72: 257–262.

    Article  PubMed  Google Scholar 

  13. Walls T, Shankar AG, Shingadia D . Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis 2003; 3: 79–86.

    Article  PubMed  Google Scholar 

  14. Kojaoghlanian T, Flomenberg P, Horwitz MS . The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 2003; 13: 155–171.

    Article  PubMed  Google Scholar 

  15. Shields AF, Hackman RC, Fife KH et al. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 1985; 312: 529–533.

    Article  CAS  PubMed  Google Scholar 

  16. La Rosa AM, Champlin RE, Mirza N et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001; 32: 871–876.

    Article  CAS  PubMed  Google Scholar 

  17. Chakrabarti S, Mautner V, Osman H et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002; 100: 1619–1627.

    Article  CAS  PubMed  Google Scholar 

  18. Schilham MW, Claas EC, van Zaane W et al. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis 2002; 35: 526–532.

    Article  PubMed  Google Scholar 

  19. Lion T, Baumgartinger R, Watzinger F et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003; 102: 1114–1120.

    Article  CAS  PubMed  Google Scholar 

  20. Leruez-Ville M, Minard V, Lacaille F et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis 2004; 38: 45–52.

    Article  CAS  PubMed  Google Scholar 

  21. Wagemaker G, Heidt PJ, Merchav S, van Bekkum DW . Abrogation of histocompatibility barriers to bone marrow transplantation in rhesus monkeys. In: Baum SJ, Ledney FD, Thierfelder SJ (eds). Exp Hematol Today. Basel: S. Karger, 1982, p 111.

    Google Scholar 

  22. Slaper-Cortenbach IC, Wijngaarden-du Bois MJ, Vries-van Rossen A et al. The depletion of T cells from haematopoietic stem cell transplants. Rheumatology (Oxford) 1999; 38: 751–754.

    Article  CAS  Google Scholar 

  23. Hale G, Waldmann H . CAMPATH-1 monoclonal antibodies in bone marrow transplantation. J Hematother 1994; 3: 15–31.

    Article  CAS  PubMed  Google Scholar 

  24. Vossen JM, Heidt PJ, van den Berg H et al. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 1990; 9: 14–22.

    Article  CAS  PubMed  Google Scholar 

  25. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  PubMed  Google Scholar 

  26. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.

    Article  CAS  PubMed  Google Scholar 

  27. Claas ECJ, Schilham MW, de Brouwer CS et al. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol 2005; 43: 1738–1744.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Templeton KE, Scheltinga SA, Sillekens P et al. Development and clinical evaluation of an internally controlled, single-tube multiplex real-time PCR assay for detection of Legionella pneumophila and other Legionella species. J Clin Microbiol 2003; 41: 4016–4021.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Cejka J, Mood DW, Kim CS . Immunoglobulin concentrations in sera of normal children: quantitation against an international reference preparation. Clin Chem 1974; 20: 656–659.

    CAS  PubMed  Google Scholar 

  30. Bruno B, Gooley T, Hackman RC et al. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant 2003; 9: 341–352.

    Article  PubMed  Google Scholar 

  31. Garnett CT, Erdman D, Xu W, Gooding LR . Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 2002; 76: 10608–10616.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Strohl WA, Schlesinger RW . Quantitative studies of natural and experimental adenovirus infections of human cells. II. Primary cultures and the possible role of asynchronous viral multiplication in the maintenance of infection. Virology 1965; 26: 208–220.

    Article  CAS  PubMed  Google Scholar 

  33. Hierholzer J . Adenoviruses in the immunocompromised host. Clin Microbiol Rev 1992; 5: 262–274.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Krilov LR, Rubin LG, Frogel M et al. Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states. Rev Infect Dis 1990; 12: 303–307.

    Article  CAS  PubMed  Google Scholar 

  35. Ferdman RM, Ross L, Inderlied C, Church JA . Adenovirus viremia in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1997; 16: 413–415.

    Article  CAS  PubMed  Google Scholar 

  36. Michaels MG, Green M, Wald ER, Starzl TE . Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 1992; 165: 170–174.

    Article  CAS  PubMed  Google Scholar 

  37. Cames B, Rahier J, Burtomboy G et al. Acute adenovirus hepatitis in liver transplant recipients. J Pediatr 1992; 120: 33–37.

    Article  CAS  PubMed  Google Scholar 

  38. McGrath D, Falagas ME, Freeman R et al. Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance. J Infect Dis 1998; 177: 459–462.

    Article  CAS  PubMed  Google Scholar 

  39. Wasserman R, August CS, Plotkin SA . Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J 1988; 7: 109–115.

    Article  CAS  PubMed  Google Scholar 

  40. Fox JP, Hall CE, Cooney MK . The Seattle virus watch. VII. Observations of adenovirus infections. Am J Epidemiol 1977; 105: 362–386.

    Article  CAS  PubMed  Google Scholar 

  41. Edwards KM, Thompson J, Paolini J, Wright PF . Adenovirus infections in young children. Pediatrics 1985; 76: 420–424.

    CAS  PubMed  Google Scholar 

  42. Fox JP, Brandt CD, Wassermann FE et al. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. Am J Epidemiol 1969; 89: 25–50.

    Article  CAS  PubMed  Google Scholar 

  43. D'Ambrosio E, Del Grosso N, Chicca A, Midulla M . Neutralizing antibodies against 33 human adenoviruses in normal children in Rome. J Hyg (London) 1982; 89: 155–161.

    Article  CAS  Google Scholar 

  44. Horwitz MS . Adenoviruses. In: Knipe DM, Howley PM (eds). Fields' Virology. Lippincott Williams & Wilkins: Philadelphia, 2001, pp 2301–2326.

    Google Scholar 

  45. Zahradnik JM, Spencer MJ, Porter DD . Adenovirus infection in the immunocompromised patient. Am J Med 1980; 68: 725–732.

    Article  CAS  PubMed  Google Scholar 

  46. Wardley AM, Jayson GC, Swindell R et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol 2000; 110: 292–299.

    Article  CAS  PubMed  Google Scholar 

  47. Kook H, Goldman F, Padley D et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 1996; 88: 1089–1097.

    CAS  PubMed  Google Scholar 

  48. Koneru B, Jaffe R, Esquivel CO et al. Adenoviral infections in pediatric liver transplant recipients. JAMA 1987; 258: 489–492.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Heemskerk B, Lankester AC, van Vreeswijk T et al. Immune reconstitution and clearance of disseminating adenovirus infection in pediatric stem cell recipients. J Infect Dis 2005; 191: 520–530.

    Article  CAS  PubMed  Google Scholar 

  50. Dagan R, Schwartz RH, Insel RA, Menegus MA . Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody. Pediatr Infect Dis 1984; 3: 246–251.

    Article  CAS  PubMed  Google Scholar 

  51. Legrand F, Berrebi D, Houhou N et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 2001; 27: 621–626.

    Article  CAS  PubMed  Google Scholar 

  52. Lankester AC, Heemskerk B, Claas EC et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis 2004; 38: 1521–1525.

    Article  CAS  PubMed  Google Scholar 

  53. Echavarria M, Forman M, van Tol MJ et al. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 2001; 358: 384–385.

    Article  CAS  PubMed  Google Scholar 

  54. Lankester AC, van Tol MJD, Claas ECJ et al. Quantification of adenovirus DNA in plasma: a role in management of stem cell graft recipients. Clin Infect Dis 2002; 34: 864–867.

    Article  CAS  PubMed  Google Scholar 

  55. Hromas R, Cornetta K, Srour E et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T cell depleted bone marrow transplantation. Blood 1994; 84: 1689–1690.

    CAS  PubMed  Google Scholar 

  56. Chakrabarti S, Collingham KE, Fegan CD et al. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplant 2000; 26: 305–307.

    Article  CAS  PubMed  Google Scholar 

  57. Heemskerk B, Veltrop-Duits LA, van Vreeswijk T et al. Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy. J Virol 2003; 77: 6562–6566.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Regn S, Raffegerst S, Chen X et al. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant. Bone Marrow Transplant 2001; 27: 53–64.

    Article  CAS  PubMed  Google Scholar 

  59. Feuchtinger T, Lang P, Hamprecht K et al. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. Exp Hematol 2004; 32: 282–289.

    Article  CAS  PubMed  Google Scholar 

  60. Leen AM, Sili U, Savoldo B et al. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 2004; 103: 1011–1019.

    Article  CAS  PubMed  Google Scholar 

  61. Andre-Schmutz I, Le Deist F, Hacein-Bey-Abina S et al. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet 2002; 360: 130–137.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Department of Paediatrics, Section of Immunology, Haematology, Oncology, Bone Marrow Transplantation and Autoimmunity, Leiden University Medical Centre (LUMC), Leiden, The Netherlands

    M J D van Tol, W Dinkelaar, C M Jol-van der Zijde & J M Vossen

  2. The Department of Medical Microbiology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands

    A C M Kroes, J Schinkel & E C J Claas

Authors
  1. M J D van Tol
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A C M Kroes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Schinkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W Dinkelaar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E C J Claas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C M Jol-van der Zijde
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J M Vossen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M J D van Tol.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Tol, M., Kroes, A., Schinkel, J. et al. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant 36, 39–50 (2005). https://doi.org/10.1038/sj.bmt.1705003

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705003

Keywords

This article is cited by

Search

Advanced search

Quick links